Disseminated Intravascular Coagulation

doi:10.1017/9781316551684.043

Chapter 42 - Disseminated Intravascular Coagulation

from Section 5 - Disorders Involving Abnormal Coagulation

Published online by Cambridge University Press: 15 June 2018

Sanam Baghshomali and

Monisha A. Kumar

Edited by

Louis Caplan and

José Biller

Show author details

Louis Caplan: Affiliation:
Beth Israel-Deaconess Medical Center, Boston
José Biller: Affiliation:
Loyola University Stritch School of Medicine, Chicago

Book contents

Get access

Summary

A summary is not available for this content so a preview has been provided. Please use the Get access link above for information on how to access this content.

Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'

Information

Type: Chapter
Information: Uncommon Causes of Stroke , pp. 317 - 327

DOI: https://doi.org/10.1017/9781316551684.043 [Opens in a new window]

Publisher: Cambridge University Press

Print publication year: 2018

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

Book purchase

Temporarily unavailable

References

Hardaway, R. M. Disseminated intravascular coagulation syndromes. Arch. Surg. Chic. Ill. 1960 83, 842–50 (1961).Google Scholar PubMed

Goodnight, S. H. et al. Defibrination after brain-tissue destruction: A serious complication of head injury. N. Engl. J. Med. 290, 1043–7 (1974).CrossRef Google Scholar PubMed

Gando, S., Nanzaki, S., Sasaki, S. & Kemmotsu, O. Significant correlations between tissue factor and thrombin markers in trauma and septic patients with disseminated intravascular coagulation. Thromb. Haemost. 79, 1111–15 (1998).Google Scholar PubMed

Gando, S. Disseminated intravascular coagulation in trauma patients. Semin. Thromb. Hemost. 27, 585–92 (2001).10.1055/s-2001-18864CrossRef Google Scholar PubMed

García-Avello, A. et al. Degree of hypercoagulability and hyperfibrinolysis is related to organ failure and prognosis after burn trauma. Thromb. Res. 89, 59–64 (1998).CrossRef Google Scholar PubMed

Barbui, T. & Falanga, A. Disseminated intravascular coagulation in acute leukemia. Semin. Thromb. Hemost. 27, 593–604 (2001).CrossRef Google Scholar PubMed

Arai, A. et al. Cardiac malignant pheochromocytoma with bone metastases. Intern. Med. Tokyo Jpn. 37, 940–4 (1998).Google Scholar PubMed

Letsky, E. A. Disseminated intravascular coagulation. Best Pract. Res. Clin. Obstet. Gynaecol. 15, 623–44 (2001).CrossRef Google Scholar PubMed

Hossain, N. & Paidas, M. J. Disseminated intravascular coagulation. Semin. Perinatol. 37, 257–66 (2013).CrossRef Google Scholar PubMed

Breakwell, L. M., Getty, C. J., & Austin, C. Disseminated intravascular coagulation in elective primary total hip replacement. J. Arthroplasty 14, 239–42 (1999).CrossRef Google Scholar PubMed

Asherson, R. A. The catastrophic antiphospholipid syndrome, 1998. A review of the clinical features, possible pathogenesis and treatment. Lupus 7, S55–62 (1998).CrossRef Google Scholar PubMed

Katsaros, D. & Grundfest-Broniatowski, S. Successful management of visceral Klippel–Trenaunay–Weber syndrome with the antifibrinolytic agent tranexamic acid (cyclocapron): A case report. Am. Surg. 64, 302–4 (1998).Google Scholar PubMed

Persoons, M. C., Stals, F. S., van dam Mieras, M. C., & Bruggeman, C. A. Multiple organ involvement during experimental cytomegalovirus infection is associated with disseminated vascular pathology. J. Pathol. 184, 103–9 (1998).10.1002/(SICI)1096-9896(199801)184:1<103::AID-PATH964>3.0.CO;2-C3.0.CO;2-C>CrossRef Google Scholar PubMed

Lifshitz, M., Kapelushnik, J., Ben-Harosh, M., & Sofer, S. Disseminated intravascular coagulation after Cerastes vipera envenomation in a 3-year-old child: A case report. Toxicon Off. J. Int. Soc. Toxinology 38, 1593–8 (2000).CrossRef Google Scholar

Bey, T. A. et al. Loxosceles arizonica bite associated with shock. Ann. Emerg. Med. 30, 701–3 (1997).10.1016/S0196-0644(97)70092-1CrossRef Google Scholar PubMed

Jung, J. W. et al. A fatal case of intravascular coagulation after bee sting acupuncture. Allergy Asthma Immunol. Res. 4, 107–9 (2012).10.4168/aair.2012.4.2.107CrossRef Google Scholar PubMed

Dhanapriya, J. et al. Acute kidney injury and disseminated intravascular coagulation due to mercuric chloride poisoning. Indian J. Nephrol. 26, 206 (2016).10.4103/0971-4065.164230CrossRef Google Scholar PubMed

Felcher, A. et al. Disseminated intravascular coagulation and status epilepticus. Neurology 51, 629–31 (1998).CrossRef Google Scholar PubMed

Bick, R. L. Disseminated intravascular coagulation. Hematol. Oncol. Clin. North Am. 6, 1259–85 (1992).10.1016/S0889-8588(18)30274-0CrossRef Google Scholar PubMed

Gando, S., Levi, M., & Toh, C.-H. Disseminated intravascular coagulation. Nat. Rev. Dis. Primer 2, 16037 (2016).CrossRef Google Scholar PubMed

Dhainaut, J.-F., Macias, W. L., & Nelson, D. R. Would patients with more subtle signs of coagulopathy have benefited from treatment with activated protein C? Crit. Care Med. 33, 1670–1 (2005).10.1097/01.CCM.0000166889.11063.07CrossRef Google Scholar

Taylor, F. B. et al. Towards definition, clinical and laboratory criteria, and a scoring system for disseminated intravascular coagulation. Thromb. Haemost. 86, 1327–30 (2001).CrossRef Google Scholar

Favaloro, E. J. & Adcock, D. M. Standardization of the INR: How good is your laboratory’s INR and can it be improved? Semin. Thromb. Hemost. 34, 593–603 (2008).CrossRef Google Scholar PubMed

Gando, S. et al. A multicenter, prospective validation of disseminated intravascular coagulation diagnostic criteria for critically ill patients: Comparing current criteria. Crit. Care Med. 34, 625–31 (2006).CrossRef Google Scholar PubMed

Prechel, M. & Walenga, J. M. The laboratory diagnosis and clinical management of patients with heparin-induced thrombocytopenia: An update. Semin. Thromb. Hemost. 34, 86–96 (2008).10.1055/s-2008-1066027CrossRef Google Scholar PubMed

Selleng, K., Selleng, S., & Greinacher, A. Heparin-induced thrombocytopenia in intensive care patients. Semin. Thromb. Hemost. 34, 425–38 (2008).CrossRef Google Scholar PubMed

Schwartzman, R. J. & Hill, J. B. Neurologic complications of disseminated intravascular coagulation. Neurology 32, 791–7 (1982).10.1212/WNL.32.8.791CrossRef Google Scholar PubMed

Shebuski, R. J. & Kilgore, K. S. Role of inflammatory mediators in thrombogenesis. J. Pharmacol. Exp. Ther. 300, 729–35 (2002).CrossRef Google Scholar PubMed

Wada, H. et al. Hemostatic molecular markers before the onset of disseminated intravascular coagulation. Am. J. Hematol. 60, 273–8 (1999).10.1002/(SICI)1096-8652(199904)60:4<273::AID-AJH4>3.0.CO;2-N3.0.CO;2-N>CrossRef Google Scholar PubMed

Favaloro, E. J. Laboratory testing in disseminated intravascular coagulation. Semin. Thromb. Hemost. 36, 458–67 (2010).10.1055/s-0030-1254055CrossRef Google Scholar PubMed

Levi, M. & van der Poll, T. The role of natural anticoagulants in the pathogenesis and management of systemic activation of coagulation and inflammation in critically ill patients. Semin. Thromb. Hemost. 34, 459–68 (2008).10.1055/s-0028-1092876CrossRef Google Scholar PubMed

de Jonge, E., van der Poll, T., Kesecioglu, J. & Levi, M. Anticoagulant factor concentrates in disseminated intravascular coagulation: Rationale for use and clinical experience. Semin. Thromb. Hemost. 27, 667–74 (2001).10.1055/s-2001-18871CrossRef Google Scholar PubMed

Naidech, A. M. & Kumar, M. A., and the participants in the International Multidisciplinary Consensus Conference on Multimodality Monitoring. Monitoring of hematological and hemostatic parameters in neurocritical care patients. Neurocrit. Care 21, 168–76 (2014).CrossRef Google Scholar PubMed

Johansson, P. I., Stensballe, J., Vindeløv, N., Perner, A., & Espersen, K. Hypocoagulability, as evaluated by thromboelastography, at admission to the ICU is associated with increased 30-day mortality. Blood Coagul. Fibrinolysis 21, 168–74 (2010).CrossRef Google Scholar

Park, M. S. et al. Thromboelastography as a better indicator of hypercoagulable state after injury than prothrombin time or activated partial thromboplastin time. J. Trauma 67, 266–76 (2009).Google Scholar PubMed

Bakhtiari, K., Meijers, J. C. M., de Jonge, E., & Levi, M. Prospective validation of the International Society of Thrombosis and Haemostasis scoring system for disseminated intravascular coagulation. Crit. Care Med. 32, 2416–21 (2004).10.1097/01.CCM.0000147769.07699.E3CrossRef Google Scholar

Gando, S. et al. Evaluation of new Japanese diagnostic criteria for disseminated intravascular coagulation in critically ill patients. Clin. Appl. Thromb. Off. J. Int. Acad. Clin. Appl. Thromb. 11, 71–6 (2005).Google Scholar PubMed

Sivula, M., Tallgren, M., & Pettilä, V. Modified score for disseminated intravascular coagulation in the critically ill. Intensive Care Med. 31, 1209–14 (2005).10.1007/s00134-005-2685-2CrossRef Google Scholar PubMed

Cauchie, P. et al. Diagnosis and prognosis of overt disseminated intravascular coagulation in a general hospital – meaning of the ISTH score system, fibrin monomers, and lipoprotein-C-reactive protein complex formation. Am. J. Hematol. 81, 414–19 (2006).CrossRef Google Scholar

Umemura, Y. et al. Design and evaluation of new unified criteria for disseminated intravascular coagulation based on the Japanese Association for Acute Medicine criteria. Clin. Appl. Thromb. Off. J. Int. Acad. Clin. Appl. Thromb. 22, 153–60 (2016).Google Scholar PubMed

Angstwurm, M. W. A., Dempfle, C.-E., & Spannagl, M. New disseminated intravascular coagulation score: A useful tool to predict mortality in comparison with Acute Physiology and Chronic Health Evaluation II and Logistic Organ Dysfunction scores. Crit. Care Med. 34, 314–20; quiz 328 (2006).10.1097/01.CCM.0000196832.27501.B2CrossRef Google Scholar

Toh, C. H. & Downey, C. Performance and prognostic importance of a new clinical and laboratory scoring system for identifying non-overt disseminated intravascular coagulation. Blood Coagul. Fibrinolysis Int. J. Haemost. Thromb. 16, 69–74 (2005).10.1097/00001721-200501000-00011CrossRef Google Scholar PubMed

Cartin-Ceba, R. et al. Epidemiology of critical care syndromes, organ failures, and life-support interventions in a suburban US community. Chest 140, 1447–55 (2011).CrossRef Google Scholar

Gando, S. et al. Natural history of disseminated intravascular coagulation diagnosed based on the newly established diagnostic criteria for critically ill patients: Results of a multicenter, prospective survey. Crit. Care Med. 36, 145–50 (2008).10.1097/01.CCM.0000295317.97245.2DCrossRef Google Scholar PubMed

Wheeler, A. P. & Bernard, G. R. Treating patients with severe sepsis. N. Engl. J. Med. 340, 207–14 (1999).CrossRef Google Scholar PubMed

Levi, M., de Jonge, E., & van der Poll, T. Sepsis and disseminated intravascular coagulation. J. Thromb. Thrombolysis 16, 43–7 (2003).10.1023/B:THRO.0000014592.27892.11CrossRef Google Scholar PubMed

Lavrentieva, A. et al. Early coagulation disorders after severe burn injury: Impact on mortality. Intensive Care Med. 34, 700–6 (2008).10.1007/s00134-007-0976-5CrossRef Google Scholar PubMed

Barret, J. P. & Gomez, P. A. Disseminated intravascular coagulation: A rare entity in burn injury. Burns J. Int. Soc. Burn Inj. 31, 354–7 (2005).10.1016/j.burns.2004.11.006CrossRef Google Scholar PubMed

Singh, B. et al. Trends in the incidence and outcomes of disseminated intravascular coagulation in critically ill patients (2004–2010): A population-based study. Chest 143, 1235–42 (2013).CrossRef Google Scholar PubMed

Ranieri, V. M. et al. Drotrecogin alfa (activated) in adults with septic shock. N. Engl. J. Med. 366, 2055–64 (2012).10.1056/NEJMoa1202290CrossRef Google Scholar PubMed

Murata, A., Okamoto, K., Mayumi, T., Muramatsu, K. & Matsuda, S. The recent time trend of outcomes of disseminated intravascular coagulation in Japan: An observational study based on a national administrative database. J. Thromb. Thrombolysis 38, 364–71 (2014).CrossRef Google Scholar PubMed

Hoffman, M. & Monroe, D. M. A cell-based model of hemostasis. Thromb. Haemost. 85, 958–65 (2001).Google Scholar PubMed

Franco, R. F. et al. The in vivo kinetics of tissue factor messenger RNA expression during human endotoxemia: Relationship with activation of coagulation. Blood 96, 554–9 (2000).10.1182/blood.V96.2.554.014k17_554_559CrossRef Google Scholar PubMed

Levi, M. & van der Poll, T. Inflammation and coagulation. Crit. Care Med. 38, S26–34 (2010).10.1097/CCM.0b013e3181c98d21CrossRef Google Scholar PubMed

Rauch, U. et al. Transfer of tissue factor from leukocytes to platelets is mediated by CD15 and tissue factor. Blood 96, 170–5 (2000).10.1182/blood.V96.1.170CrossRef Google Scholar PubMed

Zimmerman, G. A., McIntyre, T. M., Prescott, S. M., & Stafforini, D. M. The platelet-activating factor signaling system and its regulators in syndromes of inflammation and thrombosis. Crit. Care Med. 30, S294–301 (2002).CrossRef Google Scholar

Bockmeyer, C. L. et al. Inflammation-associated ADAMTS 13 deficiency promotes formation of ultra-large von Willebrand factor. Haematologica 93, 137–40 (2008).10.3324/haematol.11677CrossRef Google Scholar PubMed

Osterud, B. & Bjørklid, E. The production and availability of tissue thromboplastin in cellular populations of whole blood exposed to various concentrations of endotoxin. An assay for detection of endotoxin. Scand. J. Haematol. 29, 175–84 (1982).CrossRef Google Scholar PubMed

Engelmann, B. & Massberg, S. Thrombosis as an intravascular effector of innate immunity. Nat. Rev. Immunol. 13, 34–45 (2013).10.1038/nri3345CrossRef Google Scholar

Müller, I. et al. Intravascular tissue factor initiates coagulation via circulating microvesicles and platelets. FASEB J. Off. Publ. Fed. Am. Soc. Exp. Biol. 17, 476–8 (2003).Google Scholar PubMed

Fuchs, T. A. et al. Extracellular DNA traps promote thrombosis. Proc. Natl. Acad. Sci. USA 107, 15880–5 (2010).10.1073/pnas.1005743107CrossRef Google Scholar PubMed

von Brühl, M.-L. et al. Monocytes, neutrophils, and platelets cooperate to initiate and propagate venous thrombosis in mice in vivo. J. Exp. Med. 209, 819–35 (2012).CrossRef Google Scholar PubMed

Massberg, S. et al. Reciprocal coupling of coagulation and innate immunity via neutrophil serine proteases. Nat. Med. 16, 887–96 (2010).CrossRef Google Scholar PubMed

Franchini, M. Pathophysiology, diagnosis and treatment of disseminated intravascular coagulation: An update. Clin. Lab. 51, 633–9 (2005).Google Scholar PubMed

Lineaweaver, W., Franzini, D., Dragonetti, D., McCarley, D., & Rumley, T. Haemophilus influenzae meningitis and Waterhouse–Friderichsen syndrome in an adult. South. Med. J. 79, 1034–6 (1986).CrossRef Google Scholar PubMed

Ohashi, R. et al. Acute renal failure as the presenting sign of disseminated intravascular coagulation in a patient with metastatic prostate cancer. Int. J. Nephrol. Renov. Dis. 6, 47–51 (2013).10.2147/IJNRD.S41813CrossRef Google Scholar

Bick, R. L. Disseminated intravascular coagulation: Pathophysiological mechanisms and manifestations. Semin. Thromb. Hemost. 24, 3–18 (1998).CrossRef Google Scholar PubMed

Collins, R. C., Al-Mondhiry, H., Chernik, N. L., & Posner, J. B. Neurologic manifestations of intravascular coagulation in patients with cancer. A clinicopathologic analysis of 12 cases. Neurology 25, 795–806 (1975).CrossRef Google Scholar

Graus, F., Rogers, L. R., & Posner, J. B. Cerebrovascular complications in patients with cancer. Medicine (Baltimore) 64, 16–35 (1985).10.1097/00005792-198501000-00002CrossRef Google Scholar PubMed

Wijdicks, E. F. & Scott, J. P. Stroke in the medical intensive-care unit. Mayo Clin. Proc. 73, 642–6 (1998).CrossRef Google Scholar PubMed

Navi, B. B. et al. Intracerebral and subarachnoid hemorrhage in patients with cancer. Neurology 74, 494–501 (2010).CrossRef Google Scholar PubMed

Goodnight, S. H. Bleeding and intravascular clotting in malignancy: A review. Ann. N. Y. Acad. Sci. 230, 271–88 (1974).Google Scholar PubMed

Pisoni, R., Ruggenenti, P. & Remuzzi, G. Drug-induced thrombotic microangiopathy: Incidence, prevention and management. Drug Saf. 24, 491–501 (2001).10.2165/00002018-200124070-00002CrossRef Google Scholar PubMed

Nguyen, T. C. & Carcillo, J. A. Bench-to-bedside review: Thrombocytopenia-associated multiple organ failure – a newly appreciated syndrome in the critically ill. Crit. Care Lond. Engl. 10, 235 (2006).10.1186/cc5064CrossRef Google Scholar PubMed

Johnson, R. T. & Richardson, E. P. The neurological manifestations of systemic lupus erythematosus. Medicine (Baltimore) 47, 337–69 (1968).CrossRef Google Scholar PubMed

Musio, F., Bohen, E. M., Yuan, C. M., & Welch, P. G. Review of thrombotic thrombocytopenic purpura in the setting of systemic lupus erythematosus. Semin. Arthritis Rheum. 28, 1–19 (1998).10.1016/S0049-0172(98)80023-1CrossRef Google Scholar PubMed

Yasuda, S., Bohgaki, M., Atsumi, T. & Koike, T. Pathogenesis of antiphospholipid antibodies: Impairment of fibrinolysis and monocyte activation via the p38 mitogen-activated protein kinase pathway. Immunobiology 210, 775–80 (2005).10.1016/j.imbio.2005.10.009CrossRef Google Scholar PubMed

Galli, M. Treatment of the antiphospholipid syndrome. Auto- Immun. Highlights 5, 1–7 (2014).10.1007/s13317-013-0056-5CrossRef Google Scholar PubMed

Cervera, R. & Espinosa, G. Update on the catastrophic antiphospholipid syndrome and the ‘CAPS Registry’. Semin. Thromb. Hemost. 38, 333–8 (2012).Google Scholar PubMed

van Runnard Heimel, P. J. et al. A randomised placebo-controlled trial of prolonged prednisolone administration to patients with HELLP syndrome remote from term. Eur. J. Obstet. Gynecol. Reprod. Biol. 128, 187–193 (2006).CrossRef Google Scholar PubMed

Pijnenborg, R., Vercruysse, L., Hanssens, M. & Brosens, I. Endovascular trophoblast and preeclampsia: A reassessment. Pregnancy Hypertens. 1, 66–71 (2011).CrossRef Google Scholar PubMed

Warkentin, T. Heparin-induced thrombocytopenia in critically ill patients. Semin. Thromb. Hemost. 41, 049–60 (2015).Google Scholar PubMed

Warkentin, T. E., Sheppard, J.-A. I., Moore, J. C., Cook, R. J., & Kelton, J. G. Studies of the immune response in heparin-induced thrombocytopenia. Blood 113, 4963–9 (2009).CrossRef Google Scholar PubMed

Hanly, E. J., Cohn, E. J., Johnson, J. L., & Peyton, B. D. DIC: Treatment frontiers. Curr. Surg. 59, 257–64 (2002).CrossRef Google Scholar PubMed

Levi, M., Toh, C. H., Thachil, J., & Watson, H. G. Guidelines for the diagnosis and management of disseminated intravascular coagulation. British Committee for Standards in Haematology. Br. J. Haematol. 145, 24–33 (2009).CrossRef Google Scholar PubMed

Wada, H. et al. Expert consensus for the treatment of disseminated intravascular coagulation in Japan. Thromb. Res. 125, 6–11 (2010).10.1016/j.thromres.2009.08.017CrossRef Google Scholar PubMed

Kawasugi, K. et al. Prospective evaluation of hemostatic abnormalities in overt DIC due to various underlying diseases. Thromb. Res. 128, 186–90 (2011).CrossRef Google Scholar PubMed

Alving, B. M., Spivak, J. L., DeLoughery, T. G. Consultative hematology: Hemostasis and transfusion issues in surgery and critical care medicine. Hematology Am. Soc. Hematol. Educ. Program 320–41, 1998.Google Scholar

Slichter, S. J. Evidence-based platelet transfusion guidelines. Hematol. Am. Soc. Hematol. Educ. Program 172–78 (2007). doi:10.1182/asheducation-2007.1.172CrossRef Google Scholar

Wada, H. et al. Guidance for diagnosis and treatment of DIC from harmonization of the recommendations from three guidelines. J. Thromb. Haemost. (2013). doi:10.1111/jth.12155.CrossRef Google Scholar

Sakuragawa, N., Hasegawa, H., Maki, M., Nakagawa, M. & Nakashima, M. Clinical evaluation of low-molecular-weight heparin (FR-860) on disseminated intravascular coagulation (DIC): A multicenter co-operative double-blind trial in comparison with heparin. Thromb. Res. 72, 475–500 (1993).CrossRef Google Scholar PubMed

Simpson, E. et al. Recombinant factor VIIa for the prevention and treatment of bleeding in patients without haemophilia. Cochrane Database Syst. Rev. CD005011 (2012). doi:10.1002/14651858.CD005011.pub4.CrossRef Google Scholar

Liu, X.-L. et al. Low-dose heparin as treatment for early disseminated intravascular coagulation during sepsis: A prospective clinical study. Exp. Ther. Med. 7, 604–8 (2014).10.3892/etm.2013.1466CrossRef Google Scholar PubMed

Corrigan, J. J. & Jordan, C. M. Heparin therapy in septicemia with disseminated intravascular coagulation: Effect on mortality and on correction of hemostatic defects. N. Engl. J. Med. 283, 778–82 (1970).10.1056/NEJM197010082831502CrossRef Google Scholar

Gando, S., Sawamura, A., & Hayakawa, M. Trauma, shock, and disseminated intravascular coagulation: Lessons from the classical literature. Ann. Surg. 254, 10–19 (2011).10.1097/SLA.0b013e31821221b1CrossRef Google Scholar PubMed

Vincent, J.-L. et al. A randomized, double-blind, placebo-controlled, phase 2b study to evaluate the safety and efficacy of recombinant human soluble thrombomodulin, ART-123, in patients with sepsis and suspected disseminated intravascular coagulation. Crit. Care Med. 41, 2069–79 (2013).CrossRef Google Scholar PubMed

Jaimes, F. et al. Unfractioned heparin for treatment of sepsis: A randomized clinical trial (the HETRASE study). Crit. Care Med. 37, 1185–96 (2009).CrossRef Google Scholar PubMed

Okajima, K. & Uchiba, M. The anti-inflammatory properties of antithrombin III: new therapeutic implications. Semin. Thromb. Hemost. 24, 27–32 (1998).10.1055/s-2007-995820CrossRef Google Scholar PubMed

Fourrier, F., Jourdain, M. & Tournoys, A. Clinical trial results with antithrombin III in sepsis. Crit. Care Med. 28, S38–43 (2000).10.1097/00003246-200009001-00009CrossRef Google Scholar PubMed

Saito, H. et al. Efficacy and safety of recombinant human soluble thrombomodulin (ART-123) in disseminated intravascular coagulation: Results of a phase III, randomized, double-blind clinical trial. J. Thromb. Haemost. 5, 31–41 (2007).10.1111/j.1538-7836.2006.02267.xCrossRef Google Scholar PubMed

Yamakawa, K. et al. Treatment effects of recombinant human soluble thrombomodulin in patients with severe sepsis: A historical control study. Crit. Care Lond. Engl. 15, R123 (2011).10.1186/cc10228CrossRef Google Scholar PubMed

Abraham, E. et al. Drotrecogin alfa (activated) for adults with severe sepsis and a low risk of death. N. Engl. J. Med. 353, 1332–41 (2005).CrossRef Google Scholar

Abraham, E. et al. Assessment of the safety of recombinant tissue factor pathway inhibitor in patients with severe sepsis: A multicenter, randomized, placebo-controlled, single-blind, dose escalation study. Crit. Care Med. 29, 2081–9 (2001).CrossRef Google Scholar PubMed

CRASH-2 trial collaborators et al. Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): A randomised, placebo-controlled trial. Lancet Lond. Engl. 376, 23–32 (2010).10.1016/S0140-6736(10)60835-5CrossRef Google Scholar

CRASH-2 Collaborators, Intracranial Bleeding Study. Effect of tranexamic acid in traumatic brain injury: A nested randomised, placebo controlled trial (CRASH-2 Intracranial Bleeding Study). BMJ 343, d3795 (2011).10.1136/bmj.d3795CrossRef Google Scholar

Accessibility standard: Unknown

Why this information is here

This section outlines the accessibility features of this content - including support for screen readers, full keyboard navigation and high-contrast display options. This may not be relevant for you.

Accessibility Information

Accessibility compliance for the PDF of this book is currently unknown and may be updated in the future.